The amount of the deal was not disclosed.
The company intends to use the funds to acquire Aloha Medicinals, Inc., a biotechnology company focused on medicinal mushroom production.
Led by Don Stock, CEO, American Botanicals buys, processes, sells and exports hundreds of roots, herbs, barks, berries and other botanical products, which are purchased directly from U.S. farmers and dealers and used in products ranging from food to nutritional supplements by the company’s more than 400 customers.
Aloha Medicinals is a U.S. producer of organic medicinal mushroom raw materials. Its products are used in various pharmaceutical and nutraceutical products, as well as in specialty food products and pet treats and supplements. It also produces certified organic mushroom spawn, which is the seed stock used for cultivating edible mushrooms.
FinSMEs
22/02/2016